Table 1.
Factor | TCGA cohort I | TCGA cohort II | MCTP cohort |
---|---|---|---|
No. of patients | 255 | 157 | 67 |
Age, y, mean (SD) | 65.3 (10) | 65.3 (10.5) | 68.3 (10) |
Female sex, No. (%) | 134 (52.5) | 88 (56.1) | 36 (53.7) |
Median survivor follow-up, mo | 19.3 | 20.0 | 33 |
Smoking history, No. (%) | |||
Yes | 211 (82.7) | 128 (81.5) | NR |
No | 35 (13.7) | 24 (15.2) | NR |
Unknown | 9 (3.5) | 5 (3.2) | NR |
Stage, No. (%) | |||
I | 139 (54.5) | 88 (56.1) | 40 (59.7) |
IA | 63 (24.7) | 55 (35.0) | NR |
IB | 74 (29.0) | 30 (19.1) | NR |
II | 59 (23.13) | 40 (25.5) | 13 (19.4) |
IIA | 25 (9.8) | 19 (12.1) | NR |
IIB | 34 (13.3) | 21 (13.4) | NR |
III | 43 (16.9) | 24 (15.2) | 14 (20.9) |
IIIA | 38 (14.9) | 20 (12.7) | NR |
IIIB | 5 (1.9) | 4 (2.5) | NR |
IV | 14 (5.5) | 4 (2.5) | 0 |
*MCTP = Michigan Center for Translational Pathology; NR = not recorded; TCGA = The Cancer Genome Atlas.